How Pfizer went back to the drawing board

By Devex Editor 19 July 2016

Caroline Roan, Pfizer’s vice president of corporate responsibility, outlines what the company is doing to help achieve the Sustainable Development Goals by 2030.

How do you solve health problems for people around the world, whether or not there’s a market for it today? Pharmaceutical giant Pfizer is aiming to bring medicine to more people by starting small.

On the sidelines of Devex World, Caroline Roan, Pfizer’s vice president of corporate responsibility, told Devex President and Editor-in-Chief Raj Kumar what the company is doing to help achieve the Sustainable Development Goals by 2030. Roan discussed the company’s shift toward working directly with entrepreneurs in order to boost access to medicine.

Through cash support, for example, Pfizer is encouraging entrepreneurs with good ideas to begin to scale and, in addition, the company is looking for new financing mechanisms to help them achieve these goals.

Watch the clip above to learn more about how Pfizer is focusing on the SDGs.

Follow Focus On: Devex World for more conversations emerging from the global development event of the year.

About the author

Devex logo
Devex Editor

Thanks a lot for your interest in Devex News. To share news and views, story ideas and press releases, please email news@devex.com. We look forward to hearing from you.


Join the Discussion